drugset / Trial / NCT01700530

Exercise, Statins, and the Metabolic Syndrome

NCT01700530

RandomizedParallel-groupOpen-labelTreatment

Summary

Here we tested if statins or exercise plus statins had a greater capacity to lower metabolic syndrome risk factors in sedentary individuals with at least 2 metabolic syndrome risk factors. We also examined if statins impacted exercise response for mitochondrial content in muscle or aerobic fitness.

Timeline

Start
2007-05
Primary completion
2011-05
Completion
2011-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Simvastatin Small molecule 40 mg